Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.

To claim your copy free of charge simply follow this link.

Stephen Hoge Biography and Net Worth

President of Moderna

Stephen Hoge serves as the President of Moderna and leads all Research & Development for the company. Since Moderna’s early days, Dr. Hoge has led our scientific efforts, including the creation of our platform and therapeutic areas. More recently, he has assumed responsibility for the company’s Clinical Development Office. He joined Moderna in late 2012 from McKinsey & Company, where he was a partner in the healthcare practice. Prior to McKinsey, Dr. Hoge was a resident physician in New York City.

He holds an M.D. with thesis from the University of California, San Francisco, and a B.S. in neuroscience from Amherst College.

Currently, Dr. Hoge also serves on the Board of Directors of Axcella Health, Inc., a publicly traded, clinical-stage biotechnology company.

What is Stephen Hoge's net worth?: The estimated net worth of Stephen Hoge is at least $52.74 million as of September 3rd, 2024. Dr. Hoge owns 1,443,002 shares of Moderna stock worth more than $52,741,723 as of November 21st. This net worth approximation does not reflect any other assets that Dr. Hoge may own. Additionally, Dr. Hoge receives an annual salary of $1,920,000.00 as President at Moderna. Learn More about Stephen Hoge's net worth.
How old is Stephen Hoge?: Dr. Hoge is currently 47 years old. There are 5 older executives and no younger executives at Moderna. The oldest executive at Moderna is Dr. Jerh Collins Ph.D., Chief Technical Operations & Quality Officer, who is 57 years old. Learn More on Stephen Hoge's age.
What is Stephen Hoge's salary?: As the President of Moderna, Inc., Dr. Hoge earns $1,920,000.00 per year. The highest earning executive at Moderna is Mr. Stephane Bancel, Chief Executive Officer, who commands a salary of $4,550,000.00 per year. Learn More on Stephen Hoge's salary.
How do I contact Stephen Hoge?: The corporate mailing address for Dr. Hoge and other Moderna executives is 200 TECHNOLOGY SQUARE, CAMBRIDGE MA, 02139. Moderna can also be reached via phone at (617) 714-6500 and via email at [email protected]. Learn More on Stephen Hoge's contact information.
Has Stephen Hoge been buying or selling shares of Moderna?: Stephen Hoge has not been actively trading shares of Moderna over the course of the past ninety days. Most recently, Stephen Hoge sold 318 shares of the business's stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $76.99, for a transaction totalling $24,482.82. Following the completion of the sale, the president now directly owns 1,443,002 shares of the company's stock, valued at $111,096,723.98. Learn More on Stephen Hoge's trading history.
Who are Moderna's active insiders?: Moderna's insider roster includes Noubar Afeyan (Director), Juan Andres (Insider), Stephane Bancel (Chief Executive Officer), W. Cornwell (Director), Arpa Garay (Insider), Lori Henderson (General Counsel), Lori Henderson (General Counsel), Stephen Hoge (President), Lorence Kim (CFO), Shannon Klinger (Insider), David Meline (CFO), Jamey Mock (CFO), Elizabeth Nabel (Director), Paul Sagan (Director), and Tal Zaks (Insider). Learn More on Moderna's active insiders.
Are insiders buying or selling shares of Moderna?: During the last year, insiders at the sold shares 46 times. They sold a total of 646,276 shares worth more than $81,357,882.30. The most recent insider tranaction occured on October, 7th when CFO James M Mock sold 715 shares worth more than $42,985.80. Insiders at Moderna own 15.7% of the company. Learn More about insider trades at Moderna.
Information on this page was last updated on 10/7/2024.

Stephen Hoge Insider Trading History at Moderna

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/3/2024	Sell	318	$76.99	$24,482.82	1,443,002
8/29/2024	Sell	300	$78.03	$23,409.00	1,442,668
8/12/2024	Sell	254	$84.10	$21,361.40	1,442,357
7/15/2024	Sell	15,000	$121.12	$1,816,800.00	1,442,089
6/17/2024	Sell	15,000	$138.16	$2,072,400.00	1,457,089
5/29/2024	Sell	341	$144.50	$49,274.50	1,471,777
5/10/2024	Sell	255	$120.96	$30,844.80	1,486,508
4/15/2024	Sell	15,000	$105.02	$1,575,300.00	1,486,241
2/29/2024	Sell	2,388	$94.57	$225,833.16	1,515,898
1/16/2024	Sell	15,000	$103.90	$1,558,500.00	1,516,063
12/27/2023	Sell	45,000	$100.01	$4,500,450.00	1,531,063
12/27/2023	Sell	45,000	$100.01	$4,500,450.00	1,531,063
9/15/2023	Sell	15,000	$112.99	$1,694,850.00	1,574,187
8/29/2023	Sell	1,135	$115.01	$130,536.35	1,588,855
8/17/2023	Sell	15,000	$100.00	$1,500,000.00	1,587,579
8/10/2023	Sell	247	$102.53	$25,324.91	1,602,579
7/17/2023	Sell	15,000	$120.60	$1,809,000.00	1,602,303
6/15/2023	Sell	15,000	$125.93	$1,888,950.00	1,617,303
6/2/2023	Sell	309	$130.32	$40,268.88	1,632,303
5/30/2023	Sell	1,181	$124.95	$147,565.95	1,631,961
5/10/2023	Sell	250	$133.37	$33,342.50	1,630,732
3/1/2023	Sell	1,072	$138.03	$147,968.16	1,629,031
2/10/2023	Sell	245	$163.90	$40,155.50	1,627,693
11/29/2022	Sell	1,085	$173.80	$188,573.00	1,627,416
9/12/2022	Sell	5,000	$141.66	$708,300.00	1,625,800
8/29/2022	Sell	1,119	$135.81	$151,971.39	1,625,800
8/23/2022	Sell	5,000	$141.70	$708,500.00	1,624,509
8/15/2022	Sell	5,000	$172.85	$864,250.00	1,624,509
8/12/2022	Sell	5,000	$172.68	$863,400.00	1,624,509
8/10/2022	Sell	244	$173.66	$42,373.04	1,624,509
7/25/2022	Sell	10,000	$162.75	$1,627,500.00	1,624,231
7/13/2022	Sell	5,000	$168.88	$844,400.00	1,624,231
6/24/2022	Sell	5,000	$143.98	$719,900.00	1,624,231
6/13/2022	Sell	10,000	$123.00	$1,230,000.00	1,624,231
5/31/2022	Sell	8,430	$145.02	$1,222,518.60	1,624,231
5/10/2022	Sell	234	$133.71	$31,288.14	1,622,820
5/3/2022	Sell	10,000	$141.93	$1,419,300.00	1,622,532
4/25/2022	Sell	20,000	$143.22	$2,864,400.00	1,622,532
4/12/2022	Sell	5,000	$159.00	$795,000.00	1,622,532
4/4/2022	Sell	20,000	$177.27	$3,545,400.00	1,622,532
3/24/2022	Sell	5,000	$175.52	$877,600.00
3/18/2022	Sell	7,541	$171.67	$1,294,563.47
2/14/2022	Sell	20,000	$157.71	$3,154,200.00
2/10/2022	Sell	894	$158.89	$142,047.66
2/2/2022	Sell	10,000	$170.89	$1,708,900.00
1/24/2022	Sell	20,000	$150.67	$3,013,400.00
1/13/2022	Sell	15,000	$219.56	$3,293,400.00
12/27/2021	Sell	5,000	$243.10	$1,215,500.00
12/23/2021	Sell	15,000	$247.30	$3,709,500.00
12/13/2021	Sell	20,000	$257.01	$5,140,200.00
12/2/2021	Sell	10,000	$301.29	$3,012,900.00
11/15/2021	Sell	15,000	$231.01	$3,465,150.00
11/12/2021	Sell	5,000	$225.86	$1,129,300.00
11/3/2021	Sell	10,000	$350.00	$3,500,000.00
10/25/2021	Sell	20,000	$331.80	$6,636,000.00
10/13/2021	Sell	15,000	$314.90	$4,723,500.00
10/4/2021	Sell	20,000	$307.54	$6,150,800.00
9/24/2021	Sell	5,000	$448.04	$2,240,200.00
9/13/2021	Sell	20,000	$447.41	$8,948,200.00	1,614,597
9/2/2021	Sell	10,000	$393.13	$3,931,300.00	1,619,597
8/13/2021	Sell	15,000	$405.00	$6,075,000.00	1,614,597
7/26/2021	Sell	5,000	$351.99	$1,759,950.00	5,000
7/23/2021	Sell	15,000	$335.13	$5,026,950.00	1,614,597
7/13/2021	Sell	15,000	$238.87	$3,583,050.00	1,614,597
7/6/2021	Sell	10,000	$229.62	$2,296,200.00	1,619,597
6/23/2021	Sell	15,000	$216.20	$3,243,000.00	1,614,597
6/14/2021	Sell	20,000	$213.32	$4,266,400.00	1,614,597
5/3/2021	Sell	20,000	$183.66	$3,673,200.00
4/23/2021	Sell	15,000	$172.19	$2,582,850.00	1,614,597
4/13/2021	Sell	15,000	$146.62	$2,199,300.00	1,614,597
4/5/2021	Sell	20,000	$132.63	$2,652,600.00	1,619,597
3/24/2021	Sell	5,000	$137.07	$685,350.00	1,614,597
3/15/2021	Sell	15,000	$137.00	$2,055,000.00	1,614,597
3/12/2021	Sell	5,000	$134.04	$670,200.00	1,614,597
2/23/2021	Sell	15,000	$147.08	$2,206,200.00	1,629,597
2/12/2021	Sell	5,000	$185.00	$925,000.00	1,624,597
2/3/2021	Sell	20,000	$157.46	$3,149,200.00
1/25/2021	Sell	20,000	$140.97	$2,819,400.00	1,649,597
1/13/2021	Sell	15,000	$123.70	$1,855,500.00	1,644,597
12/23/2020	Sell	10,000	$124.14	$1,241,400.00	1,734,597
12/14/2020	Sell	20,000	$163.63	$3,272,600.00	1,744,597
12/2/2020	Sell	10,000	$138.57	$1,385,700.00	1,744,597
11/24/2020	Sell	5,000	$97.93	$489,650.00	1,754,597
11/13/2020	Sell	20,000	$86.82	$1,736,400.00
10/26/2020	Sell	5,000	$69.99	$349,950.00	1,926,530
10/23/2020	Sell	15,000	$70.02	$1,050,300.00	1,926,530
10/12/2020	Sell	5,000	$74.46	$372,300.00	1,925,521
10/5/2020	Sell	10,000	$69.50	$695,000.00	1,936,530
10/2/2020	Sell	10,000	$67.86	$678,600.00	1,936,530
9/24/2020	Sell	20,000	$66.72	$1,334,400.00	1,946,530
9/14/2020	Sell	20,000	$61.42	$1,228,400.00	1,956,530
9/2/2020	Sell	10,000	$62.89	$628,900.00	1,956,530
8/24/2020	Sell	20,000	$64.99	$1,299,800.00	1,966,530
8/13/2020	Sell	20,000	$69.03	$1,380,600.00
8/3/2020	Sell	20,000	$74.89	$1,497,800.00	1,976,530
7/24/2020	Sell	20,000	$78.86	$1,577,200.00	1,986,530
7/13/2020	Sell	10,000	$69.92	$699,200.00	1,986,530
7/6/2020	Sell	10,000	$58.48	$584,800.00	1,986,540
7/2/2020	Sell	10,000	$59.94	$599,400.00	1,986,540
6/23/2020	Sell	5,000	$63.69	$318,450.00	1,983,531
6/15/2020	Sell	10,000	$63.32	$633,200.00
5/26/2020	Sell	10,000	$61.85	$618,500.00	2,005,495
5/12/2020	Sell	5,000	$64.50	$322,500.00	2,015,657
4/23/2020	Sell	5,000	$49.02	$245,100.00	2,025,140
3/23/2020	Sell	5,000	$27.93	$139,650.00	2,045,267
1/23/2020	Sell	5,000	$21.99	$109,950.00	2,081,915
1/13/2020	Sell	10,000	$19.14	$191,400.00	2,086,530

Stephen Hoge Buying and Selling Activity at Moderna

Moderna Company Overview

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $36.55

$36.02

$36.70

50 Day Range

MA: $56.13

$36.85

$71.99

2 Week Range

Now: $36.55

$35.80

$170.47

Volume

834,475 shs

Average Volume

4,765,115 shs

Market Capitalization

$14.07 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.69

Download Our Tesla Ebook For Free

From DTI | Ad

To claim your copy free of charge simply follow this link.

Stephen Hoge Biography and Net Worth

What is Stephen Hoge's net worth?

How old is Stephen Hoge?

What is Stephen Hoge's salary?

How do I contact Stephen Hoge?

Has Stephen Hoge been buying or selling shares of Moderna?

Who are Moderna's active insiders?

Are insiders buying or selling shares of Moderna?